| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.24 | 4e-11 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.31 | 4e-08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |